Voloridge Investment Management
DCPH

Voloridge Investment Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Voloridge Investment Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-182,059
Closed -$2.86M – 1406
2024
Q1 		$2.86M Sell
182,059
-12,170
-6% -$187K 0.01% 779
2023
Q4 		$3.13M Buy
+194,229
New +$2.48M 0.01% 722
2023
Q1 		– Sell
-233,699
Closed -$3.83M – 1668
2022
Q4 		$3.83M Sell
233,699
-49,649
-18% -$807K 0.02% 754
2022
Q3 		$5.24M Sell
283,348
-72,790
-20% -$1.14M 0.03% 638
2022
Q2 		$4.68M Sell
356,138
-260,735
-42% -$2.88M 0.02% 705
2022
Q1 		$5.72M Buy
616,873
+173,111
+39% +$1.47M 0.03% 591
2021
Q4 		$4.34M Buy
+443,762
New +$8.35M 0.02% 772
2020
Q1 		– Sell
-32,263
Closed -$2.01M – 1465
2019
Q4 		$2.01M Buy
32,263
+3,609
+13% +$172K 0.04% 489
2019
Q3 		$973K Buy
+28,654
New +$848K 0.02% 648

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Voloridge Investment Management's DCPH Position: Q2 2024 in Review

Voloridge Investment Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 182,059 shares — an estimated $2.86M sold.

Voloridge Investment Management first reported a position in DCPH in Q3 2019 and held it in 9 quarters. The position peaked at $5.72M in Q1 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Voloridge Investment Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 182,059 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $2.86M.
  • Voloridge Investment Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 9 quarters.
  • Voloridge Investment Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $5.72M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Voloridge Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.